Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDSJ J Goedert, M E Sauter, L P Jacobson, et al.
The New England Journal of Medicine|May 21, 1992
Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositisF W Miller, S F Leitman, M E Cronin, et al.
Immunohematology|September 18, 2004
Intravenous Rh immune globulin prevents alloimmunization in D- granulocyte recipients but obscures the detection of an allo-anti-KD F Stroncek, J L Procter, L Moses, et al.
Annals of Internal Medicine|October 1, 1990
Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infectionH C Lane, K M Zunich, W Wilson, et al.
Human Gene Therapy|October 9, 1999
Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC)J M Liu, S Kim, E J Read, et al.
Transfusion|May 1, 1994
Guidelines for blood utilization reviewL Stehling, N L Luban, K C Anderson, et al.
Journal of Immunological Methods|August 3, 1987
Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapyL M Muul, K Nason-Burchenal, C S Carter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancerM W Saif, S F Leitman, G Cusack, et al.
The New England Journal of Medicine|October 5, 1989
Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donorsS F Leitman, H G Klein, J J Melpolder, et al.
British Journal of Haematology|November 28, 2001
Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-backR Nakamura, E Bahceci, E J Read, et al.
Pageof 8